Showing 201-210 of 18100 results for "".
New Treatment Algorithm for Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/new-treatment-algorithm-for-type-2-diabetes/6178/The recent American Diabetes Association / European Association for the Study of Diabetes consensus panel produced their treatment algorithm to control glycaemia in type 2 diabetes. How can healthcare professionals treating patients with type 2 diabetes provide additional prandial intervention to reDietary Decisions for Patients with Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/dietary-decisions-for-treating-patients-with-type-2-diabetes/12095/How does a patient’s diet play a role in treating type 2 diabetes?Taking a New Approach to Treat Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/taking-a-new-approach-to-treat-type-1-diabetes/12509/Do we need to shift our focus when it comes to type 1 diabetes treatment?A New Paradigm for the Treatment of Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/a-new-paradigm-for-the-treatment-of-type-2-diabetes/4803/Insulin resistance in muscle, liver and ß-cell represent the core pathophysiologic defects in type 2 diabetes. In addition, the ominous octet all play important roles in the development of glucose intolerance in people with type 2 diabetes. How will this new paradigm shift our understanding in the wState of the Art Treatment of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/state-of-the-art-treatment-of-type-1-diabetes/1105/How has the management of diabetes changed for children in the last 20 years? Join Dr. William Tamborlane with an update on the state of the art treatments for type 1 diabetes.Optimizing Athletic Performance in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/optimizing-athletic-performance-in-type-1-diabetes/6386/Patients living with type 1 diabetes who are involved in athletics present particular challenges to approaching to their management, medication regimen and nutrition. How can healthcare professionals help their type 1 athletes optimize their performance and manage their diabetes? Join host Dr. SteveInvestigating the Link Between Type 2 Diabetes & Obesity
https://reachmd.com/programs/diabetes-discourse/investigating-the-link-between-type-2-diabetes-obesity/12632/Are there differences between type 2 diabetes in males and females, and is this disease linked to obesity?The Benefits of TZDs for Early Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/the-benefits-of-tzds-for-early-type-2-diabetes/5343/Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesisNovel Therapies for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/novel-therapies-for-type-1-diabetes/1767/How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease phyType 1 Diabetes: Control and Cure
https://reachmd.com/programs/clinicians-roundtable/type-1-diabetes-control-and-cure/1771/Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug c